Hong Kong's Prenetics agrees $1.25b SPAC merger
Hong Kong-based genetic testing business Prenetics has agreed to merge with a special purpose acquisition company (SPAC) sponsored by Adrian Cheng, scion of local property developer New World Development and managing partner of C Ventures, at an enterprise valuation of $1.25 billion.
Prenetics has raised $85 million in funding to date, including a $40 million round led by Alibaba Group’s Hong Kong Entrepreneur Fund and Beyond Ventures in 2017, and a $15 million round led by Apis...
More on Greater China
Latest News
Ince leads $30m round for China’s PhiGent Robotics
Beijing-based autonomous driving solutions provider PhiGent Robotics has raised a USD30m Series A round led by Ince Capital. Previous investors such as Atypical Ventures, 5Y Capital, and GSR Ventures re-upped.
China's BlueRun $819m across US dollar, renminbi funds
China-based BlueRun Ventures has closed its third US dollar-denominated China fund and third renminbi vehicle with aggregate commitments of CNY 5.5bn (USD 819m).
Singapore's Azalea targets $754m PE-backed bond offering
Temasek Holdings-owned Azalea Investment Management is further expanding retail exposure to private equity through its latest issue of bonds – worth USD 754m in total – backed by LP interests in funds.
Hong Kong's Betatron hits $15m first close on VC fund
Hong Kong’s Betatron Venture Group has reached a first close of USD 15m on its latest fund, which will make early-stage investments across South and Southeast Asia. The target is USD 50m.